Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
1,100.23
-25.70 (-2.28%)
At close: Jun 24, 2026
Market Cap5.50B +160.7%
Revenue (ttm)3.12B +24.9%
Net Income499.00M +43.3%
EPS99.80 +43.3%
Shares Out 5.00M
PE Ratio11.02
Forward PEn/a
Dividend62.95 (5.72%)
Ex-Dividend DateNov 4, 2025
Volume851
Open1,125.93
Previous Close1,125.93
Day's Range1,095.00 - 1,125.93
52-Week Range421.00 - 1,239.00
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateSep 3, 2026

About EGX:AXPH

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Indus... [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol AXPH
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:AXPH's revenue was 2.75 billion, an increase of 55.56% compared to the previous year's 1.77 billion. Earnings were 391.17 million, an increase of 80.53%.

Financial Statements